Preoperative Algorithm Might Halve Unnecessary Oophorectomies in Children Researchers point to potential for reduction in lifelong consequences Oct 03, 2023
ABIM CEO Retirement Comes Amid Wave of Criticism Richard Baron, MD, plans to step down as pushback against MOC grows Oct 02, 2023
SABR Offers New Hope for Older Patients With Inoperable Kidney Cancer Phase II study shows 100% local control and cancer-specific survival after more than 3 years Oct 01, 2023
IV Immunoglobulin May Cut Infection Risk of Anti-BCMA Agents for Myeloma Small retrospective study finds fewer severe infections during periods of replacement therapy Sep 29, 2023
New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
Anti-TIGIT Plus Immunotherapy 'Promising' in NSCLC, Esophageal Cancer Combination may "provide meaningful antitumor activity," researchers say Sep 28, 2023
Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screening News, features, and commentary about cancer-related issues Sep 28, 2023
Report: Persistence of Gender Inequalities in Cancer Care, and a Call to Action Premature deaths, lack of access to services, leadership inequalities highlighted Sep 27, 2023
Cancer Risk in NAFLD Higher With Early Disease Onset 52% greater risk of malignancy for patients diagnosed with fatty liver disease before age 45 Sep 27, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
Study Confirms Better Survival for HPV-Positive Cervical Cancer Source, interpretation of negative tests remain open to speculation Sep 26, 2023
When Screening Guidelines Collide, Who Wins? A closer look at conflicting colorectal cancer screening recommendations Sep 26, 2023
Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia And almost all complete responders in small trial achieved MRD negativity Sep 25, 2023
Reduced Mortality Seen in Cancer Survivors Who Meet Exercise Guidelines Survivors classified as exercisers have 25% reduced risk of all-cause mortality, study shows Sep 23, 2023
The White House Cancer Moonshot Is a Dud We're failing to take simple steps to reduce one of the biggest causes of cancer Sep 22, 2023
TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology News, features, and commentary about cancer-related issues Sep 21, 2023
Ultrasound May Help Early Breast Cancer Patients Avoid SLNB No axillary surgery matches SLNB for patients with a negative ultrasound of axillary lymph nodes Sep 21, 2023
Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer Threefold risk reduction with enoxaparin in high-risk gastrointestinal, lung cancers Sep 21, 2023
Delaying Esophageal Cancer Surgery After Neoadjuvant CRT Fails in Trial Histological complete response rates no better and survival appears worse Sep 19, 2023
Large Study Eases Fears Over Zantac-Cancer Link In multinational cohort, cancer incidence with pulled drug no different than other H2RAs Sep 19, 2023
Could Cetuximab Maintenance Play a Role in RAS Wild-Type Metastatic CRC? Strategy tied to better outcomes but fails to meet primary goal of phase II trial Sep 18, 2023
FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosis In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly Sep 18, 2023
Non-Erosive GERD May Not Increase Risk of Esophageal Cancer Study shows similar incidence rates to general population, unlike for those with erosive GERD Sep 18, 2023
Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
Weight-Loss Surgery Tied to Lower Blood Cancer Risk in Women Consider surgery for primary prevention in people with obesity, researchers suggest Sep 15, 2023
Cisplatin Shortage Eases; Air Pollution Linked to Breast Cancer; Pap Test Confusion News, features, and commentary about cancer-related issues Sep 15, 2023
No 'Silver Bullet' for Generic Drug Shortage, House Members Told A total of 301 drugs were in active shortage last year Sep 14, 2023
Individualized SABR for Lung Tumors Yields Low Recurrence Rates Strategy also results in low rates of severe toxic effects Sep 14, 2023
IMRT Best for Locally Advanced NSCLC, Study Suggests Technique reduces risk of severe lung toxicity and radiation to the heart compared with 3D-CRT Sep 13, 2023
Early Oophorectomy May Accelerate Onset of Chronic Health Problems Premenopausal bilateral oophorectomy tied to higher odds of arthritis, sleep apnea, and more Sep 13, 2023
Novel Antibody-Drug Conjugate Shows Efficacy in Advanced EGFR-Mutated NSCLC Confirmed responses reached 29.8% in heavily pretreated patients Sep 13, 2023
Study Questions Use of Aggressive Surgery in Early Mesothelioma Randomized data suggest surgery increases risk of death by 28% over first 42 months Sep 12, 2023
Adding First-Line Chemo Boosts PFS in EGFR-Mutant Lung Cancer Osimertinib plus chemotherapy improved PFS by nearly 9 months versus targeted agent alone Sep 12, 2023
Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myeloma Motixafortide plus filgrastim increased adequate harvest rate from 9.5% to 67.5% Sep 11, 2023
FLT3 Inhibitor Improves AML Survival With or Without Stem-Cell Transplant Best outcomes with transplantation, but non-transplant patients also benefited from quizartinib Sep 11, 2023
First-Line Triplet Yields 'Striking' OS Result in Extensive-Stage SCLC Median overall survival reached 19.3 months in Chinese trial Sep 11, 2023
Opt-Out Strategy Fails to Improve Breast Cancer Screening Completion Rates Opt-out vs opt-in approach also resulted in more canceled referrals, increasing burden for staff Sep 11, 2023
High Rate of Durable Responses in R/R Lymphoma With Bispecific Antibody Response rate exceeds 60%, with 15- to 20-month duration with epcoritamab Sep 11, 2023
How Vital Drug Shortages Happen "Fundamentally, there's something broken in how the market works" Sep 11, 2023 video
